Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013

NCT ID: NCT01747369

Last Updated: 2017-03-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-04-30

Study Completion Date

2017-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to estimate the burden of disease due to pneumococci, other bacteria and viruses in the African meningitis belt prior to pneumococcal conjugate vaccine introduction and to estimate the population impact of the vaccine after its implementation in 2014. In a defined population of a sanitary district in northern Togo, during the period 2010 to 2017, investigators enroll patients of all ages with suspected pneumonia requiring hospitalization or suspected bacterial meningitis. Patients are evaluated by bacteriology and molecular biology techniques on blood, cerebro-spinal fluid, nasal aspirates and by chest X-ray.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonia, Bacterial Pneumonia, Viral Meningitis, Bacterial

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* resident of Tône sanitary district - requiring hospitalisation for at least one night for clinical pneumonia syndrome
* hospitalised in a study site during the study period


* resident of Tône sanitary district
* presenting clinical signs of acute bacterial meningitis
* hospitalised in a study site during the study period

Exclusion Criteria

* absence of informed consent by patient or legal tutor

Meningitis surveillance:


* absence of informed consent by patient or legal tutor
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Region Sanitaire des Savanes, Togo

UNKNOWN

Sponsor Role collaborator

Ministere de la Sante et de la Promotion Sociale, Togo

UNKNOWN

Sponsor Role collaborator

Institut National d'Hygiene, Togo

UNKNOWN

Sponsor Role collaborator

Centre Muraz

OTHER

Sponsor Role collaborator

Fondation Mérieux, France

UNKNOWN

Sponsor Role collaborator

Pfizer

INDUSTRY

Sponsor Role collaborator

Agence de Médecine Préventive, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jennifer C Moïsi, PhD

Role: PRINCIPAL_INVESTIGATOR

Agence de Médecine Préventive

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Régional (CHR) Savanes

Dapaong, Savanes, Togo

Site Status RECRUITING

Clinique Win' Pang

Dapaong, Savanes, Togo

Site Status RECRUITING

Hôpital d'enfants Yendubé

Dapaong, Savanes, Togo

Site Status RECRUITING

Polyclinique

Dapaong, Savanes, Togo

Site Status RECRUITING

Centre médico-social (CMS)

Sinkassé, Savanes, Togo

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Togo

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Makawa-Sy Makawa, MD

Role: CONTACT

+228-921 29 31

Haoua Tall, PharmD MPH

Role: CONTACT

+226-50300406

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PneumoTone

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pneumonia Chart Review Cambodia
NCT03260413 WITHDRAWN